ChartMill assigns a Buy % Consensus number of 82% to DRIO. The Buy consensus is the weighted average rating of the current analysts ratings.
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-05-19 | Litchfield Hills | Initiate | Buy |
| 2025-03-11 | Stifel | Maintains | Buy -> Buy |
| 2024-04-01 | Stifel | Maintains | Buy -> Buy |
| 2023-08-11 | Alliance Global Partners | Maintains | Buy -> Buy |
| 2023-07-25 | Stifel | Maintains | Buy -> Buy |
| 2023-05-12 | Craig-Hallum | Maintains | Buy -> Buy |
| 2022-11-16 | Alliance Global Partners | Maintains | Buy |
| 2022-08-18 | Aegis Capital | Maintains | Buy |
| 2022-08-16 | Cowen & Co. | Maintains | Outperform |
| 2022-05-16 | Aegis Capital | Maintains | Buy |
| 2022-05-16 | Cowen & Co. | Maintains | Outperform |
| 2022-05-13 | Alliance Global Partners | Upgrade | Neutral -> Buy |
| 2022-01-26 | Aegis Capital | Maintains | Buy |
| 2021-08-19 | Aegis Capital | Maintains | Buy |
| 2021-04-22 | Cowen & Co. | Initiate | Outperform |
| 2021-03-23 | Stifel | Initiate | Buy |
| 2021-02-08 | Aegis Capital | Maintains | Buy |
10 analysts have analysed DRIO and the average price target is 18.61 USD. This implies a price increase of 53.08% is expected in the next year compared to the current price of 12.16.
The consensus rating for DARIOHEALTH CORP (DRIO) is 82 / 100 . This indicates that analysts generally have a positive outlook on the stock.
The number of analysts covering DARIOHEALTH CORP (DRIO) is 10.